Mazdutide is an innovative GLP-1 (glucagon-like peptide-1) and GCG (glucagon) dual receptor agonist, mainly used to treat type 2 diabetes and obesity. It enhances insulin secretion, suppresses appetite and promotes energy consumption through dual mechanisms, thereby significantly improving blood sugar control and effectively reducing weight. Clinical studies have shown that Mazdutide performs well in both blood sugar reduction and weight loss, providing a new treatment option for patients with metabolic diseases.
Product Overview
Basic Description |
Structure and function: |
Three-letter sequence |
His - {Aib}-Gln - Gly - Thr - Phe - Thr - Ser - Asp - Tyr - Ser - Lys - Tyr - Leu - Asp - Glu - Lys - Lys - Ala - Lys - {AEEA - AEEA - γGlu - nonadecanoic acid}-Glu - Phe - Val - Glu - Trp - Leu - Leu - Glu - Gly - Gly - Pro - Ser - Ser - Gly - NH2 |
Single letter sequence |
H - {Aib}-QG TFT SDY SKYLDE KKAK - {AEEA - AEEA - γGlu - nonadecanoic acid}-EFVE WLL EGGPS SG - NH2 |
CAS Number |
2259884-03-0 |
Molecular formula |
C210H322N46O67 |
Molecular weight |
4563.06g/mol |
Product Attributes
purity |
>98% |
form |
Lyophilized powder |
Storage conditions |
Store at -20°C/-80°C away from light |